Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
24 Results for "
IRAK4 protein
" in MedChemExpress (MCE) Product Catalog:
Products (24)
24 Results for "IRAK4 protein" in MCE Product Catalog:
33
Research Areas:
Takinib (EDHS-206) is an orally active and selective TAK1 inhibitor (IC50=9.5 nM), more than 1.5 log more potent than the second and third ranked targets, IRAK4 (120 nM) and IRAK1 (390 nM), respectively. Takinib is an inhibitor of autophosphorylated TAK1 that non-competitively binds within the ATP binding pocket. Takinib induces apoptosis following TNFα stimulation in cell models of rheumatoid arthritis and metastatic breast cancer. Takinib is also a P. falciparum protein kinase 9 (PfPK9) inhibitor (KD(app) of 0.46 μM) .
2
Target:
Research Areas:
Zabedosertib (BAY 1834845) is a selective, orally active IRAK4 inhibitor with immunomodulatory potential, IC50 is 3.55 nM. IRAK4 is a protein kinase involved in signaling innate immune responses from Toll-like receptors . Zabedosertib exhibits anti-inflammatory property against IL-β, LPS (HY-D1056) and Imiquimod (HY-B1080) induced inflammation .
Cat. No.: HY-41547
CAS No.: 835616-60-9
Synonyms: Cereblon ligand 4; E3 ligase Ligand 4
Target:
Research Areas:
Thalidomide 4-fluoride (Cereblon ligand 4) is the Thalidomide-based Cereblon ligand used in the recruitment of CRBN protein. Thalidomide 4-fluoride (Cereblon ligand 4) can be connected to the ligand for IRAK4 protein by a linker to form PROTAC IRAK4 degrader-1 (HY-129966) .
Cat. No.: HY-W087383
CAS No.: 835616-61-0
Target:
Research Areas:
Thalidomide 5-fluoride is a thalidomide-based Cereblon ligand used to recruit Cereblon protein. Thalidomide 5-fluoride can be linked to target protein ligands (e.g. IRAK4) through a linker to form PROTAC molecules (e.g. PROTAC IRAK4 degrader-1). PROTAC IRAK4 degrader-1 caused <20%, >20-50%, and >50% IRAK4 protein degradation in OCI-LY-10 cells at concentrations of 0.01, 0.1, and 1 μM, respectively .
JNJ-1013 is a potent and selective IRAK1 PROTAC degrader with an IC50s of 72, 443, 1071 nM for IRAK1, IRAK4, VHL FP respectively. JNJ-1013 induces apoptosis and increases the expression of cleavaged PARP. JNJ-1013 decreases the expression IRAK1, p-IKBα, pSTAT3(Tyr705) (Pink: ligand for target protein (HY-138834); black: linker (HY-Y1760); Blue: E3 ligase ligand (HY-112078)) .
Cat. No.: HY-77048
CAS No.: 301675-24-1
Target:
Research Areas:
IRAK-4 protein kinase inhibitor 2 (compound 1) is a potent inhibitor of interleukin-1 (IL-1) receptor-associated kinase-4 (IRAK-4), with an IC50 of 4 μM. IRAK-4 protein kinase inhibitor 2 can be used for the research of inflammatory and immune-related conditions or disorders .
Cat. No.: HY-145484
CAS No.: 2434848-46-9
Research Areas:
PROTAC IRAK4 ligand-3 is a ligand for target protein for PROTAC, targeting IRAK4, can be used for synthesis of PROTAC KT-474 (HY-145483). PROTAC IRAK4 ligand-3 can be used in cancer research .
Cat. No.: HY-E70731
Target:
Research Areas:
The IRAK4 protein is a serine/threonine protein kinase that is critical for initiating the innate immune response through the Toll-like receptor (TLR) and IL-1R signaling pathways. After TLR is activated, it rapidly forms the Myddosome with IRAK2. IRAK4 aa104-460 Recombinant Human Active Protein Kinase is a recombinant IRAK4 aa104-460 protein that can be used to study IRAK4 aa104-460-related functions .
Cat. No.: HY-179095
CAS No.: 2597345-07-6
Research Areas:
UR241-2 is an IRAK4 inhibitor. UR241-2 suppresses IL-1–induced IRAK1/4 signaling, NF-κβ activation, and phosphorylation of p65 and p38. UR241-2 selectively inhibits leukemia stem cell clonogenicity. UR241-2 can serve as a ligand for target proteins for PROTAC, facilitating the development and design of PROTAC degraders for IRAK4. UR241-2 can be used in the research of acute myeloid leukemia .
Cat. No.: HY-168611
CAS No.: 2434841-55-9
Research Areas:
IRAK4 ligand-18 is a Ligand for Target Protein for PROTAC with antitumor activity. PROTAC IRAK4 ligand-4 can be used to synthesize PROTAC IRAK4 degrader-12 (HY-168586) .
Cat. No.: HY-158760
CAS No.: 3033830-07-5
Research Areas:
PROTAC IRAK4 degrader-11 is an imidazopyridine-based PROTAC IRAK4 degrader that degrades IRAK4 protein with a DC50 of 2.29 nM. PROTAC IRAK4 degrader-11 can be used in the research of IRAK4-related diseases, such as immune-related diseases .
Cat. No.: HY-172591
CAS No.: 3023848-94-1
Research Areas:
IRAK4 ligand-13 is a IRAK4 ligand. IRAK4 ligand-13 is a ligand for Target Protein for PROTAC. IRAK4 ligand-13 can be used for synthesis of PROTACs, such as LZ-07 (HY-172591) .
Cat. No.: HY-168586
CAS No.: 2919995-09-6
Target:
Research Areas:
PROTAC IRAK4 degrader-12 is an orally active IRAK4 PROTAC degrader with a DC50 of 4.87 nM in K562 IRAK4-HiBiT cells. PROTAC IRAK4 degrader-12 induces protein degradation of IRAK4, IKZF1 and IKZF3. It inhibits the proliferation of diffuse large B-cell lymphoma cells. It suppresses tumor growth in mouse xenograft models of lymphoma cells. PROTAC IRAK4 degrader-12 can be used for the research of B-cell lymphoma and diffuse large B-cell lymphoma .
Cat. No.: HY-48932
CAS No.: 2573304-97-7
Research Areas:
IRAK4 ligand-12 is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). IRAK4 ligand-12 can be used for the synthesis of KTX-951 (HY-148290) .
Cat. No.: HY-168311
CAS No.: 2654056-24-1
Research Areas:
PROTAC IRAK4 ligand-5 is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). PROTAC IRAK4 ligand-5 can be utilized for the synthesis of KT-413 (HY-153368) .
Cat. No.: HY-162538
CAS No.: 3053823-69-8
Research Areas:
LC-MI-3 is an orally active IRAK4 PROTAC degrader with an IC50 of 57.2 nM and high selectivity among human protein kinases. LC-MI-3 eliminates IRAK4 kinase and scaffolding functions via the cereblon E3 ubiquitin ligase and ubiquitin-proteasome systems. LC-MI-3 inhibits downstream nuclear factor-κB and IRAK4-mediated inflammatory signaling pathways. LC-MI-3 can be used for the research of acute lung injury, sepsis, psoriasis, and inflammatory diseases .
Cat. No.: HY-103490R
CAS No.: 1111556-37-6
Synonyms: EDHS-206 (Standard)
Target:
Research Areas:
Takinib (Standard) is the analytical standard of Takinib. This product is intended for research and analytical applications. Takinib (EDHS-206) is an orally active and selective TAK1 inhibitor (IC50=9.5 nM), more than 1.5 log more potent than the second and third ranked targets, IRAK4 (120 nM) and IRAK1 (390 nM), respectively. Takinib is an inhibitor of autophosphorylated TAK1 that non-competitively binds within the ATP binding pocket. Takinib induces apoptosis following TNFα stimulation in cell models of rheumatoid arthritis and metastatic breast cancer. Takinib is also a P. falciparum protein kinase 9 (PfPK9) inhibitor (KD(app) of 0.46 μM) .
Cat. No.: HY-184916
CAS No.: 3065496-12-7
Research Areas:
IRAK4 ligand-17 is a ligand for the target protein of PROTAC that targets IRAK4 (ligand for target protein for PROTAC), and it can be used for the synthesis of the PROTAC APH003 (HY-184915) .
Cat. No.: HY-P703078
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IRAK4; Interleukin-1 Receptor Associated Kinase 4 Mutant Form 2; Interleukin 1 Receptor Associated Kinase 4; Interleukin-1 Receptor-Associated Kinase 4 Isoform 2; Interleukin-1 Receptor-Associated Kinase 4; Non-Specific Serine/Threonine protein Kinase; NY
Species:
Mouse
Source:
E. coli
Cat. No.: HY-P73255
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: IRAK4; Interleukin-1 Receptor Associated Kinase 4 Mutant Form 2; Interleukin 1 Receptor Associated Kinase 4; Interleukin-1 Receptor-Associated Kinase 4 Isoform 2; Interleukin-1 Receptor-Associated Kinase 4; Non-Specific Serine/Threonine protein Kinase; NY
Species:
Human
Source:
Sf9 insect cells
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
